206 related articles for article (PubMed ID: 23579486)
21. Identification and characterization of novel estrogen receptor-beta-sparing antiprogestins.
Sathya G; Jansen MS; Nagel SC; Cook CE; McDonnell DP
Endocrinology; 2002 Aug; 143(8):3071-82. PubMed ID: 12130573
[TBL] [Abstract][Full Text] [Related]
22. Recent advances in structure of progestins and their binding to progesterone receptors.
Cabeza M; Heuze Y; Sánchez A; Garrido M; Bratoeff E
J Enzyme Inhib Med Chem; 2015 Feb; 30(1):152-9. PubMed ID: 24666307
[TBL] [Abstract][Full Text] [Related]
23. The antagonists RU486 and ZK98299 stimulate progesterone receptor binding to deoxyribonucleic acid in vitro and in vivo, but have distinct effects on receptor conformation.
Gass EK; Leonhardt SA; Nordeen SK; Edwards DP
Endocrinology; 1998 Apr; 139(4):1905-19. PubMed ID: 9528977
[TBL] [Abstract][Full Text] [Related]
24. Characterization of a new class of selective nonsteroidal progesterone receptor agonists.
Dong Y; Roberge JY; Wang Z; Wang X; Tamasi J; Dell V; Golla R; Corte JR; Liu Y; Fang T; Anthony MN; Schnur DM; Agler ML; Dickson JK; Lawrence RM; Prack MM; Seethala R; Feyen JH
Steroids; 2004 Mar; 69(3):201-17. PubMed ID: 15072922
[TBL] [Abstract][Full Text] [Related]
25. Hormone-dependent interaction between the amino- and carboxyl-terminal domains of progesterone receptor in vitro and in vivo.
Tetel MJ; Giangrande PH; Leonhardt SA; McDonnell DP; Edwards DP
Mol Endocrinol; 1999 Jun; 13(6):910-24. PubMed ID: 10379890
[TBL] [Abstract][Full Text] [Related]
26. The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor.
Vegeto E; Allan GF; Schrader WT; Tsai MJ; McDonnell DP; O'Malley BW
Cell; 1992 May; 69(4):703-13. PubMed ID: 1586949
[TBL] [Abstract][Full Text] [Related]
27. In vitro characterization of ZK 230211--A type III progesterone receptor antagonist with enhanced antiproliferative properties.
Afhüppe W; Beekman JM; Otto C; Korr D; Hoffmann J; Fuhrmann U; Möller C
J Steroid Biochem Mol Biol; 2010 Mar; 119(1-2):45-55. PubMed ID: 20043998
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and identification of novel oxa-steroids as progesterone receptor antagonists.
Kang FA; Allan G; Guan J; Jain N; Linton O; Tannenbaum P; Xu J; Zhu P; Gunnet J; Chen X; Demarest K; Lundeen S; Sui Z
Bioorg Med Chem Lett; 2007 Feb; 17(4):907-10. PubMed ID: 17169557
[TBL] [Abstract][Full Text] [Related]
29. Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells.
Yin P; Roqueiro D; Huang L; Owen JK; Xie A; Navarro A; Monsivais D; Coon JS; Kim JJ; Dai Y; Bulun SE
PLoS One; 2012; 7(1):e29021. PubMed ID: 22272226
[TBL] [Abstract][Full Text] [Related]
30. Characterization of ligand binding, DNA binding and phosphorylation of progesterone receptor by two novel progesterone receptor antagonist ligands.
Hurd C; Underwood B; Herman M; Iwasaki K; Kloosterboer HJ; Dinda S; Moudgil VK
Mol Cell Biochem; 1997 Oct; 175(1-2):205-12. PubMed ID: 9350053
[TBL] [Abstract][Full Text] [Related]
31. E1A-mediated repression of progesterone receptor-dependent transactivation involves inhibition of the assembly of a multisubunit coactivation complex.
Xu Y; Klein-Hitpass L; Bagchi MK
Mol Cell Biol; 2000 Mar; 20(6):2138-46. PubMed ID: 10688660
[TBL] [Abstract][Full Text] [Related]
32. Selective interactions of Kruppel-like factor 9/basic transcription element-binding protein with progesterone receptor isoforms A and B determine transcriptional activity of progesterone-responsive genes in endometrial epithelial cells.
Zhang XL; Zhang D; Michel FJ; Blum JL; Simmen FA; Simmen RC
J Biol Chem; 2003 Jun; 278(24):21474-82. PubMed ID: 12672823
[TBL] [Abstract][Full Text] [Related]
33. Amino-terminal domain of TIF2 is involved in competing for corepressor binding to glucocorticoid and progesterone receptors.
Wang D; Wang Q; Awasthi S; Simons SS
Biochemistry; 2007 Jul; 46(27):8036-49. PubMed ID: 17571860
[TBL] [Abstract][Full Text] [Related]
34. R5020 and RU486 act as progesterone receptor agonists to enhance Sp1/Sp4-dependent gene transcription by an indirect mechanism.
Shatnawi A; Tran T; Ratnam M
Mol Endocrinol; 2007 Mar; 21(3):635-50. PubMed ID: 17192405
[TBL] [Abstract][Full Text] [Related]
35. New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP.
Sartorius CA; Groshong SD; Miller LA; Powell RL; Tung L; Takimoto GS; Horwitz KB
Cancer Res; 1994 Jul; 54(14):3868-77. PubMed ID: 8033109
[TBL] [Abstract][Full Text] [Related]
36. The transcriptional repressor GATAD2B mediates progesterone receptor suppression of myometrial contractile gene expression.
Chen CC; Montalbano AP; Hussain I; Lee WR; Mendelson CR
J Biol Chem; 2017 Jul; 292(30):12560-12576. PubMed ID: 28576827
[TBL] [Abstract][Full Text] [Related]
37. Tamoxifen resistant breast cancer: coregulators determine the direction of transcription by antagonist-occupied steroid receptors.
Takimoto GS; Graham JD; Jackson TA; Tung L; Powell RL; Horwitz LD; Horwitz KB
J Steroid Biochem Mol Biol; 1999; 69(1-6):45-50. PubMed ID: 10418980
[TBL] [Abstract][Full Text] [Related]
38. Comparison between steroid binding to membrane progesterone receptor alpha (mPRalpha) and to nuclear progesterone receptor: correlation with physicochemical properties assessed by comparative molecular field analysis and identification of mPRalpha-specific agonists.
Kelder J; Azevedo R; Pang Y; de Vlieg J; Dong J; Thomas P
Steroids; 2010 Apr; 75(4-5):314-22. PubMed ID: 20096719
[TBL] [Abstract][Full Text] [Related]
39. Steroid hormone receptors and coregulators in endocrine-resistant and estrogen-independent breast cancer cells.
Sarvilinna N; Eronen H; Miettinen S; Vienonen A; Ylikomi T
Int J Cancer; 2006 Feb; 118(4):832-40. PubMed ID: 16152593
[TBL] [Abstract][Full Text] [Related]
40. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
Hoffmann J; Sommer A
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
